Literature DB >> 3397767

Leukoencephalopathy complicating intraventricular catheters: clinical, radiographic and pathologic study of 10 cases.

W Lemann1, R G Wiley, J B Posner.   

Abstract

Ten patients with implanted Ommaya devices developed pericatheter white matter lesions, apparent as focal lucenaries on computed tomographic scan sometimes with contrast enhancement and/or mass effect. Some of the patients had significant neurological signs that related to the lesion. Three of the patients had not received cytotoxic drugs through the reservoir, and two had received neither intrathecal chemotherapy nor cranial radiation therapy. The process appears to be related to back flow of cerebrospinal fluid, with or without contained cytotoxic drugs into the periventricular white matter. Patients with elevated intracranial pressure are at particular risk. Removal of the catheter relieves the condition.

Entities:  

Mesh:

Year:  1988        PMID: 3397767     DOI: 10.1007/bf00163543

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid.

Authors:  A K Ommaya
Journal:  Lancet       Date:  1963-11-09       Impact factor: 79.321

2.  Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.

Authors:  H Norrell; C B Wilson; D E Slagel; D B Clark
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

3.  Necrotizing encephalopathy following intraventricular instillation of methotrexate.

Authors:  W R Shapiro; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1973-02

4.  Experience with the subcutaneous cerebrospinal-fluid reservoir. Preliminary report of 60 cases.

Authors:  R A Ratcheson; A K Ommaya
Journal:  N Engl J Med       Date:  1968-11-07       Impact factor: 91.245

5.  Ommaya reservoirs in 387 cancer patients: a 15-year experience.

Authors:  E A Obbens; M E Leavens; J W Beal; Y Y Lee
Journal:  Neurology       Date:  1985-09       Impact factor: 9.910

6.  Cerebrospinal fluid edema: a rare complication of shunt operations for hydrocephalus. Report of three cases.

Authors:  Y Chiba; H Takagi; F Nakajima; S Fujii; T Kitahara; S Yagishita; Y Itoh
Journal:  J Neurosurg       Date:  1982-11       Impact factor: 5.115

7.  Cerebral biopsy and assessment of brain damage in hydrocephalus.

Authors:  R O Weller; B N Williams
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

8.  Necrotising leukoencephalopathy complicating treatment of childhood leukaemia.

Authors:  O Robain; O Dulac; J P Dommergues; F Bernaudin; K Diebler; C Kalifa; J Poirier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

9.  Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography.

Authors:  S A Grossman; D L Trump; D C Chen; G Thompson; E E Camargo
Journal:  Am J Med       Date:  1982-11       Impact factor: 4.965

10.  The Ommaya reservoir: newly recognized complications and recommendations for insertion and use.

Authors:  W A Bleyer; P A Pizzo; A M Spence; W D Platt; D R Benjamin; C J Kolins; D G Poplack
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

View more
  3 in total

1.  Complications related to the placement of an intraventricular chemotherapy device.

Authors:  Fahed Zairi; Emilie Le Rhun; Marie Charlotte Tetard; Nuria Kotecki; Richard Assaker
Journal:  J Neurooncol       Date:  2010-11-25       Impact factor: 4.130

2.  Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.

Authors:  R de Waal; P R Algra; J J Heimans; J G Wolbers; P Scheltens
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

3.  Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments.

Authors:  Alessandra Erbetta; Andrea Salmaggi; Angelo Sghirlanzoni; Antonio Silvani; Paolo Potepan; Andrea Botturi; Elisa Ciceri; Maria Grazia Bruzzone
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.